No abstract available
MeSH terms
-
Acute Disease
-
Anticoagulants / therapeutic use
-
Heparin / therapeutic use
-
Humans
-
Patient Selection
-
Plasminogen Activators / therapeutic use*
-
Pulmonary Embolism / drug therapy*
-
Pulmonary Embolism / mortality
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins / therapeutic use
-
Recurrence
-
Streptokinase / therapeutic use
-
Thrombolytic Therapy* / adverse effects
-
Thrombolytic Therapy* / standards
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Anticoagulants
-
Recombinant Proteins
-
Heparin
-
Streptokinase
-
Plasminogen Activators
-
Tissue Plasminogen Activator
-
Urokinase-Type Plasminogen Activator